On Android
Visit the form at:
vigiflow-eforms.who-umc.org/iq/iqadr (opens in a new tab)Tap the three dots in the corner of your browser
Select “Add to Home screen”
A new icon will appear on your home screen for quick access.
3rdIraqi Pharmacovigilance Conference
On the sidelines of
MedSafetyWeek 2026
5–6Dec.
2026
Babylon Rotana Hotel,Baghdad
Welcome
Dear Esteemed Colleagues and Distinguished Guests,
On the sidelines of MedSafetyWeek 2026, we are pleased to welcome you to the 3rd Iraqi Pharmacovigilance Conference, hosted by the Iraqi Pharmacovigilance Centre, Directorate of Technical Affairs, Ministry of Health.
Following last year’s focus on strengthening pharmacovigilance systems and risk minimization, this year’s conference turns to pharmacovigilance audits and inspections — key tools for verifying compliance, identifying gaps, and ensuring that systems work effectively in practice across both public and private sectors.
Together, we can strengthen pharmacovigilance practice, foster collaboration, and advance patient safety in Iraq.
The Organizing CommitteeIraqi Pharmacovigilance Centre
Audits and inspections are not only regulatory requirements; they are opportunities to strengthen quality, accountability, and continuous improvement.
Topics &
objectives
Strengthen pharmacovigilance audit and inspection practices across public and private sectors to enhance compliance, quality, accountability, and patient safety.
-
Pharmacovigilance Inspections
We will walk through the inspection lifecycle from the regulator’s and the inspected party’s perspectives. Topics include the legal basis and scope of inspections, routine versus for-cause triggers, and how inspection outcomes feed into regulatory decisions.
-
Preparing for Inspection: The Evidence Trail
A practical focus on inspection readiness for marketing authorization holders and healthcare institutions. Discussions will cover the Pharmacovigilance System Master File as a living document, data quality and traceability, and the documentation inspectors expect to find. We will review the most common findings and how to avoid them.
-
Pharmacovigilance Audits and CAPA
Audit is the internal counterpart to inspection. This session covers risk-based audit planning, audit scope and independence, and audit of outsourced activities. It closes with what happens after a finding — root cause analysis, corrective and preventive action, and verifying that the fix held.
Who should attend
Regulators and inspectors, marketing authorization holders, and healthcare institutions from both the public and private sectors.
Side effectsDon’t ignore them,report them
#MedSafetyWeek is an annual social media campaign that asks patients, caregivers and healthcare professionals to report suspected side effects of medicines. Every report adds to what regulators know about how medicines behave in everyday use, and helps make them safer for everyone.
The 3rd Iraqi Pharmacovigilance Conference takes place on the sidelines of MedSafetyWeek 2026, bringing the campaign’s message to the people who build, audit and inspect the systems that act on those reports.
#MedSafetyWeekUse the hashtag when you share the campaign.
Report a side effect
Every report makes a difference
Access the form to document side effects and treatment-related issues.
National reporting form: vigiflow-eforms.who-umc.org/iq/iqadr (opens in a new tab)
Severe symptoms? Go to the emergency room.
In case of severe symptoms such as shortness of breath, chest pain or bleeding, go to the emergency room immediately instead of reporting.
Install the form as an app
Add the reporting form to your phone’s home screen so it opens in one tap, like an app.
On iPhone
Visit the form at:
vigiflow-eforms.who-umc.org/iq/iqadr (opens in a new tab)Tap the Share button at the bottom of the page
Select “Add to Home Screen”
A new icon will appear on your home screen for quick access.
Frequently asked questions
How do you document a report?
Enter the basic information: the medicine name, dosage, dates, side effect, and any available test results. Add a contact method for follow-up if needed (kept confidential).
What should I report?
- Suspected side effects from any medicine or vaccine (such as skin rash, injection reactions, dizziness — even if you’re not sure of the cause).
- Quality issues (color or smell changes, damaged packaging, difficulty opening, or reduced effectiveness).
- Medication errors or drug interactions that may affect patient safety.
When should I call an ambulance instead of reporting?
In case of severe symptoms (such as shortness of breath, chest pain, bleeding, etc.), go to the emergency room immediately.
Who can submit a report?
Anyone (whether a patient, caregiver, or someone close to the patient) can report side effects. These reports help identify new adverse reactions and gather more information about known ones, improving medicine safety overall.
Will I get a response?
The Iraqi Pharmacovigilance Centre may contact you for additional information if needed to help assess the case.
What happens after submitting a report?
Reports are reviewed by the Pharmacovigilance Centre and securely stored in the national database to support medicine safety improvement.
Should I report even if I’m not sure?
Yes, report any suspected side effect.
Ready to report?
Report now (opens the national reporting form in a new tab)Past editions
The Iraqi Pharmacovigilance Conference meets each year on the sidelines of MedSafetyWeek. Here is a look back at earlier editions.
2025: 2nd Iraqi Pharmacovigilance Conference
2024: 1st Iraqi Pharmacovigilance Conference
Testimonials
Were you at the 2nd Iraqi Pharmacovigilance Conference in December 2025? Tell us about your experience. The organizing team reviews every testimonial before it appears on this page.
No testimonials yet
Yours could be the first. Approved testimonials appear here for everyone who visits the site.
Bulletins
The Iraqi Pharmacovigilance Bulletin is a periodic publication of the Iraqi Pharmacovigilance Centre, sharing national adverse drug reaction data, safety reviews and selected cases from Iraq’s national database.
Latest issue
Volume 3, Issue 1
January–June 2025
In this issue
- Post-Marketing Surveillance of Locally Manufactured Medicines
- Dangerous Gains: Unauthorized Beauty and Fitness Products in Iraq
- Medroxyprogesterone Acetate and Meningioma Risk
- Antimicrobial Resistance: Insights from Pharmacovigilance in Iraq
- Medication Safety Challenges in Newborn and Child Care
- Oxytocin: On the Front Lines of Maternal Safety
- Unsupervised Use of Potassium Iodide: Pharmacovigilance Notes
- Selected Cases from the National ADR Database
Earlier issues
Volume 2, Issue 2July–December 2024 (PDF, opens in a new tab)- The First Annual MedSafetyWeek Celebration
- A Year in Review: The 2024 National ADR Database Report
- GLP-1 Analogues in Obesity Management
Volume 2, Issue 1January–June 2024 (PDF, opens in a new tab)- Strengthening the Pharmacovigilance System for Local Manufacturers
- Severe Cutaneous Adverse Reactions in Iraq
- Pregnancy Prevention Program for Teratogenic Medicines
Volume 1, Issue 2December 2023 (PDF, opens in a new tab)- Medication Errors: A Comprehensive Analysis of 2023
- Biological and Biosimilar Medicines Monitoring
- Additional Risk Minimization Measures: 2023 Summary
First bulletinAugust 2023 (PDF, opens in a new tab)- Voluntary Withdrawals Report
- Mid-Year 2023 National ADR Database Summary
- Case Study: Stevens-Johnson Syndrome Caused by Etoricoxib
Guidelines, the reporting form and every bulletin are also on the Iraqi Pharmacovigilance Centre’s website.
Visit iqphvc.online (opens in a new tab)Registration
Registration is quick and completed online. Your place is confirmed once approved by the Organizing Committee.
- Step 1
Enter your phone number
Provide your phone number to receive a verification code.
- Step 2
Verify the code
Enter the code sent to confirm your number.
- Step 3
Complete your account
Enter your full name and choose your preferred contact language (English, Arabic, or Kurdish), then complete registration.
- Step 4
Select the conference
Choose MedSafetyWeek and tap Register Now.
- Step 5
Select your specialty
Choose your specialty to complete your registration.
- Step 6
Await approval
Your registration is marked pending until the Organizing Committee reviews and approves it.
Scan to register
Or open the registration page directly:
admin.leftsphere.com/registration/XCC4ZRE (opens in a new tab)
Date and venue
When
5–6 December 2026
Saturday and Sunday
Where
Babylon Rotana Hotel
Baghdad, Iraq
Hosted by
Iraqi Pharmacovigilance CentreDirectorate of Technical Affairs
Iraqi Ministry of Health
Delivered with
Left Sphere is a healthcare events and medical communications partner, delivering scientific conferences, workshops, medical simulations and educational meetings. From delegate registration and abstract management to on-site coordination and digital solutions, Left Sphere provides end-to-end support that lets medical societies focus on the science.
Left Sphere is proud to partner with the Iraqi Pharmacovigilance Centre to deliver the MedSafetyWeek event. For questions about the conference or your registration, get in touch: